6EDL

hALK in complex with compound 1 (S)-N-(1-(2,4-difluorophenyl)ethyl)-3-(3-methyl-1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-6-amine

Summary for 6EDL

Entry DOI	10.2210/pdb6edl/pdb
Descriptor	ALK tyrosine kinase receptor, N-[(1S)-1-(2,4-difluorophenyl)ethyl]-3-(5-methyl-1H-pyrazol-3-yl)imidazo[1,2-b]pyridazin-6-amine (3 entities in total)
Functional Keywords	inhibitor, complex, kinase, sbdd, transferase-inhibitor complex, transferase/inhibitor
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	36399.73
Authors	Lane, W.,Saikatendu, K. (deposition date: 2018-08-09, release date: 2019-05-01, Last modification date: 2024-03-13)
Primary citation	Fushimi, M.,Fujimori, I.,Wakabayashi, T.,Hasui, T.,Kawakita, Y.,Imamura, K.,Kato, T.,Murakami, M.,Ishii, T.,Kikko, Y.,Kasahara, M.,Nakatani, A.,Hiura, Y.,Miyamoto, M.,Saikatendu, K.,Zou, H.,Lane, S.W.,Lawson, J.D.,Imoto, H. Discovery of Potent, Selective, and Brain-Penetrant 1 H-Pyrazol-5-yl-1 H-pyrrolo[2,3- b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors. J.Med.Chem., 62:4915-4935, 2019 Cited by PubMed: 31009559 DOI: 10.1021/acs.jmedchem.8b01630 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.799 Å)

Structure validation